Loading clinical trials...
Loading clinical trials...
Cardiac damage is the second leading cause of death in patients with sarcoidosis, after lung damage. Today's challenge is to diagnose the disease as effectively as possible, and to develop tools for b...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
NCT06510894 · Cardiac Sarcoidosis
NCT06131112 · Cardiac Sarcoidosis
NCT04758650 · Solid Malignancy Located in the Head and Neck, Cancer, and more
NCT03599414 · Interstitial Lung Disease, Pulmonary Sarcoidosis, and more
NCT05793398 · Cardiac Sarcoidosis
Henri Mondor Hospital
Créteil
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions